| molecular function |
|---|
| | GO:0003677 | | DNA binding | | Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid). |
| | GO:0001102 | | RNA polymerase II activating transcription factor binding | | Interacting selectively and non-covalently with an RNA polymerase II transcription activating factor, a protein involved in positive regulation of transcription. |
| | GO:0050681 | | androgen receptor binding | | Interacting selectively and non-covalently with an androgen receptor. |
| | GO:0001047 | | core promoter binding | | Interacting selectively and non-covalently with the regulatory region composed of the transcription start site and binding sites for the basal transcription machinery. Binding may occur as a sequence specific interaction or as an interaction observed only once a factor has been recruited to the DNA by other factors. |
| | GO:0019899 | | enzyme binding | | Interacting selectively and non-covalently with any enzyme. |
| | GO:0042802 | | identical protein binding | | Interacting selectively and non-covalently with an identical protein or proteins. |
| | GO:0019900 | | kinase binding | | Interacting selectively and non-covalently with a kinase, any enzyme that catalyzes the transfer of a phosphate group. |
| | GO:0051219 | | phosphoprotein binding | | Interacting selectively and non-covalently with a phosphorylated protein. |
| | GO:0005515 | | protein binding | | Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). |
| | GO:0003713 | | transcription coactivator activity | | Interacting selectively and non-covalently with a activating transcription factor and also with the basal transcription machinery in order to increase the frequency, rate or extent of transcription. Cofactors generally do not bind the template nucleic acid, but rather mediate protein-protein interactions between activating transcription factors and the basal transcription machinery. |
| | GO:0003700 | | transcription factor activity, sequence-specific DNA binding | | Interacting selectively and non-covalently with a specific DNA sequence in order to modulate transcription. The transcription factor may or may not also interact selectively with a protein or macromolecular complex. |
| | GO:0008134 | | transcription factor binding | | Interacting selectively and non-covalently with a transcription factor, any protein required to initiate or regulate transcription. |
| | GO:0031625 | | ubiquitin protein ligase binding | | Interacting selectively and non-covalently with a ubiquitin protein ligase enzyme, any of the E3 proteins. |
| biological process |
|---|
| | GO:0000082 | | G1/S transition of mitotic cell cycle | | The mitotic cell cycle transition by which a cell in G1 commits to S phase. The process begins with the build up of G1 cyclin-dependent kinase (G1 CDK), resulting in the activation of transcription of G1 cyclins. The process ends with the positive feedback of the G1 cyclins on the G1 CDK which commits the cell to S phase, in which DNA replication is initiated. |
| | GO:0007265 | | Ras protein signal transduction | | A series of molecular signals within the cell that are mediated by a member of the Ras superfamily of proteins switching to a GTP-bound active state. |
| | GO:0030521 | | androgen receptor signaling pathway | | Any series of molecular signals generated as a consequence of an androgen binding to its receptor. |
| | GO:0006915 | | apoptotic process | | A programmed cell death process which begins when a cell receives an internal (e.g. DNA damage) or external signal (e.g. an extracellular death ligand), and proceeds through a series of biochemical events (signaling pathway phase) which trigger an execution phase. The execution phase is the last step of an apoptotic process, and is typically characterized by rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), plasma membrane blebbing and fragmentation of the cell into apoptotic bodies. When the execution phase is completed, the cell has died. |
| | GO:0007049 | | cell cycle | | The progression of biochemical and morphological phases and events that occur in a cell during successive cell replication or nuclear replication events. Canonically, the cell cycle comprises the replication and segregation of genetic material followed by the division of the cell, but in endocycles or syncytial cells nuclear replication or nuclear division may not be followed by cell division. |
| | GO:0007050 | | cell cycle arrest | | A regulatory process that halts progression through the cell cycle during one of the normal phases (G1, S, G2, M). |
| | GO:0000075 | | cell cycle checkpoint | | A cell cycle process that controls cell cycle progression by monitoring the integrity of specific cell cycle events. A cell cycle checkpoint begins with detection of deficiencies or defects and ends with signal transduction. |
| | GO:0051301 | | cell division | | The process resulting in division and partitioning of components of a cell to form more cells; may or may not be accompanied by the physical separation of a cell into distinct, individually membrane-bounded daughter cells. |
| | GO:0048667 | | cell morphogenesis involved in neuron differentiation | | The process in which the structures of a neuron are generated and organized. This process occurs while the initially relatively unspecialized cell is acquiring the specialized features of a neuron. |
| | GO:0071466 | | cellular response to xenobiotic stimulus | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a xenobiotic compound stimulus. Xenobiotic compounds are compounds foreign to living organisms. |
| | GO:0006338 | | chromatin remodeling | | Dynamic structural changes to eukaryotic chromatin occurring throughout the cell division cycle. These changes range from the local changes necessary for transcriptional regulation to global changes necessary for chromosome segregation. |
| | GO:0048565 | | digestive tract development | | The process whose specific outcome is the progression of the digestive tract over time, from its formation to the mature structure. The digestive tract is the anatomical structure through which food passes and is processed. |
| | GO:0043353 | | enucleate erythrocyte differentiation | | The process in which a myeloid precursor cell acquires specialized features of an erythrocyte without a nucleus. An example of this process is found in Mus musculus. |
| | GO:0034349 | | glial cell apoptotic process | | Any apoptotic process in a glial cell, a non-neuronal cell of the nervous system. |
| | GO:0097284 | | hepatocyte apoptotic process | | Any apoptotic process in a hepatocyte, the main structural component of the liver. |
| | GO:0034088 | | maintenance of mitotic sister chromatid cohesion | | The process in which the association between sister chromatids of a replicated chromosome is maintained as chromosomes condense, attach to the spindle in a bipolar orientation, and congress to the metaphase plate during a mitotic cell cycle. |
| | GO:0007093 | | mitotic cell cycle checkpoint | | A cell cycle checkpoint that ensures accurate chromosome replication and segregation by preventing progression through a mitotic cell cycle until conditions are suitable for the cell to proceed to the next stage. |
| | GO:0045445 | | myoblast differentiation | | The process in which a relatively unspecialized cell acquires specialized features of a myoblast. A myoblast is a mononucleate cell type that, by fusion with other myoblasts, gives rise to the myotubes that eventually develop into striated muscle fibers. |
| | GO:2000134 | | negative regulation of G1/S transition of mitotic cell cycle | | Any cell cycle regulatory process that prevents the commitment of a cell from G1 to S phase of the mitotic cell cycle. |
| | GO:0045786 | | negative regulation of cell cycle | | Any process that stops, prevents or reduces the rate or extent of progression through the cell cycle. |
| | GO:0008285 | | negative regulation of cell proliferation | | Any process that stops, prevents or reduces the rate or extent of cell proliferation. |
| | GO:0050680 | | negative regulation of epithelial cell proliferation | | Any process that stops, prevents or reduces the rate or extent of epithelial cell proliferation. |
| | GO:0010629 | | negative regulation of gene expression | | Any process that decreases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form. |
| | GO:0045930 | | negative regulation of mitotic cell cycle | | Any process that stops, prevents or reduces the rate or extent of progression through the mitotic cell cycle. |
| | GO:0006469 | | negative regulation of protein kinase activity | | Any process that stops, prevents, or reduces the frequency, rate or extent of protein kinase activity. |
| | GO:0043433 | | negative regulation of sequence-specific DNA binding transcription factor activity | | Any process that stops, prevents, or reduces the frequency, rate or extent of the activity of a transcription factor, any factor involved in the initiation or regulation of transcription. |
| | GO:0045879 | | negative regulation of smoothened signaling pathway | | Any process that stops, prevents, or reduces the frequency, rate or extent of smoothened signaling. |
| | GO:0000122 | | negative regulation of transcription from RNA polymerase II promoter | | Any process that stops, prevents, or reduces the frequency, rate or extent of transcription from an RNA polymerase II promoter. |
| | GO:0007070 | | negative regulation of transcription from RNA polymerase II promoter during mitotic cell cycle | | Any process that stops, prevents, or reduces the frequency, rate or extent of transcription from an RNA polymerase II promoter that occurs during the mitotic cell cycle. |
| | GO:0071930 | | negative regulation of transcription involved in G1/S transition of mitotic cell cycle | | Any process that stop, prevents or decreases transcription as part of the G1/S transition of the mitotic cell cycle. |
| | GO:0045892 | | negative regulation of transcription, DNA-templated | | Any process that stops, prevents, or reduces the frequency, rate or extent of cellular DNA-templated transcription. |
| | GO:0051402 | | neuron apoptotic process | | Any apoptotic process in a neuron, the basic cellular unit of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the nervous system. |
| | GO:0030182 | | neuron differentiation | | The process in which a relatively unspecialized cell acquires specialized features of a neuron. |
| | GO:0042551 | | neuron maturation | | A developmental process, independent of morphogenetic (shape) change, that is required for a neuron to attain its fully functional state. |
| | GO:0031175 | | neuron projection development | | The process whose specific outcome is the progression of a neuron projection over time, from its formation to the mature structure. A neuron projection is any process extending from a neural cell, such as axons or dendrites (collectively called neurites). |
| | GO:0045651 | | positive regulation of macrophage differentiation | | Any process that activates or increases the frequency, rate or extent of macrophage differentiation. |
| | GO:0045842 | | positive regulation of mitotic metaphase/anaphase transition | | Any process that activates or increases the frequency, rate or extent of the cell cycle process in which a cell progresses from metaphase to anaphase during mitosis, triggered by the activation of the anaphase promoting complex by Cdc20/Sleepy homolog which results in the degradation of Securin. |
| | GO:0045944 | | positive regulation of transcription from RNA polymerase II promoter | | Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter. |
| | GO:2000679 | | positive regulation of transcription regulatory region DNA binding | | Any process that activates or increases the frequency, rate or extent of transcription regulatory region DNA binding. |
| | GO:0045893 | | positive regulation of transcription, DNA-templated | | Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription. |
| | GO:0071459 | | protein localization to chromosome, centromeric region | | Any process in which a protein is transported to, or maintained at, the centromeric region of a chromosome. |
| | GO:0051726 | | regulation of cell cycle | | Any process that modulates the rate or extent of progression through the cell cycle. |
| | GO:0090230 | | regulation of centromere complex assembly | | Any process that modulates the rate, frequency, or extent of centromere complex assembly, the aggregation, arrangement and bonding together of proteins and centromeric DNA molecules to form a centromeric protein-DNA complex. |
| | GO:0071922 | | regulation of cohesin loading | | Any process that modulates the frequency, rate or extent of a process in which a cohesin complex is transported to, or maintained at, a part of a chromosome that is organized into chromatin. |
| | GO:0043550 | | regulation of lipid kinase activity | | Any process that modulates the frequency, rate or extent of lipid kinase activity, the catalysis of the transfer of a phosphate group, usually from ATP, to a simple or complex lipid. |
| | GO:0007346 | | regulation of mitotic cell cycle | | Any process that modulates the rate or extent of progress through the mitotic cell cycle. |
| | GO:0006357 | | regulation of transcription from RNA polymerase II promoter | | Any process that modulates the frequency, rate or extent of transcription from an RNA polymerase II promoter. |
| | GO:0000083 | | regulation of transcription involved in G1/S transition of mitotic cell cycle | | Any process that regulates transcription such that the target genes are involved in the transition between G1 and S phase of the mitotic cell cycle. |
| | GO:0006355 | | regulation of transcription, DNA-templated | | Any process that modulates the frequency, rate or extent of cellular DNA-templated transcription. |
| | GO:0031134 | | sister chromatid biorientation | | The cell cycle process in which sister chromatids establish stable attachments to microtubules emanating from opposite spindle poles. |
| | GO:0035914 | | skeletal muscle cell differentiation | | The process in which a relatively unspecialized cell acquires specialized features of a skeletal muscle cell, a somatic cell located in skeletal muscle. |
| | GO:0051146 | | striated muscle cell differentiation | | The process in which a relatively unspecialized cell acquires specialized features of a striated muscle cell; striated muscle fibers are divided by transverse bands into striations, and cardiac and voluntary muscle are types of striated muscle. |
| | GO:0006351 | | transcription, DNA-templated | | The cellular synthesis of RNA on a template of DNA. |
| | GO:0016032 | | viral process | | A multi-organism process in which a virus is a participant. The other participant is the host. Includes infection of a host cell, replication of the viral genome, and assembly of progeny virus particles. In some cases the viral genetic material may integrate into the host genome and only subsequently, under particular circumstances, 'complete' its life cycle. |
| cellular component |
|---|
| | GO:0016605 | | PML body | | A class of nuclear body; they react against SP100 auto-antibodies (PML, promyelocytic leukemia); cells typically contain 10-30 PML bodies per nucleus; alterations in the localization of PML bodies occurs after viral infection. |
| | GO:0035189 | | Rb-E2F complex | | A multiprotein complex containing a heterodimeric E2F transcription factor and a Retinoblastoma (Rb) family member. This complex is capable of repressing transcription of E2F-regulated genes in order to regulate cell cycle progression. |
| | GO:0016514 | | SWI/SNF complex | | A SWI/SNF-type complex that contains nine or more proteins, including both conserved (core) and nonconserved components; the Swi2/Snf2 ATPase is one of the core components. |
| | GO:0000785 | | chromatin | | The ordered and organized complex of DNA, protein, and sometimes RNA, that forms the chromosome. |
| | GO:0008024 | | cyclin/CDK positive transcription elongation factor complex | | A transcription elongation factor complex that facilitates the transition from abortive to productive elongation by phosphorylating the CTD domain of the large subunit of DNA-directed RNA polymerase II, holoenzyme. Contains a cyclin and a cyclin-dependent protein kinase catalytic subunit. |
| | GO:0005654 | | nucleoplasm | | That part of the nuclear content other than the chromosomes or the nucleolus. |
| | GO:0005634 | | nucleus | | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. |
| | GO:0005819 | | spindle | | The array of microtubules and associated molecules that forms between opposite poles of a eukaryotic cell during mitosis or meiosis and serves to move the duplicated chromosomes apart. |
| | GO:0005667 | | transcription factor complex | | A protein complex that is capable of associating with DNA by direct binding, or via other DNA-binding proteins or complexes, and regulating transcription. |
Description
